Pediatrix Medical Group, Inc.
MD
$19.70
-$0.19-0.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.71% | -3.58% | -7.03% | -7.42% | 1.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.71% | -3.58% | -7.03% | -7.42% | 1.19% |
| Cost of Revenue | -1.62% | -10.60% | -11.81% | -11.12% | -5.42% |
| Gross Profit | -1.98% | 20.14% | 9.30% | 8.18% | 27.04% |
| SG&A Expenses | 3.35% | 4.60% | -1.50% | -2.65% | 19.77% |
| Depreciation & Amortization | -18.07% | -11.24% | -39.56% | -48.27% | -24.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.16% | -8.69% | -11.06% | -10.85% | -2.87% |
| Operating Income | -5.90% | 41.11% | 30.63% | 58.81% | 48.82% |
| Income Before Tax | 36.81% | 247.84% | 132.77% | 259.02% | 124.00% |
| Income Tax Expenses | 318.26% | 177.36% | 206.84% | 94.06% | 119.56% |
| Earnings from Continuing Operations | 10.51% | 268.85% | 125.66% | 413.93% | 124.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.51% | 268.85% | 125.66% | 413.93% | 124.52% |
| EBIT | -5.90% | 41.11% | 30.63% | 58.81% | 48.82% |
| EBITDA | -7.19% | 35.53% | 19.91% | 26.98% | 35.07% |
| EPS Basic | 11.48% | 265.77% | 125.21% | 404.31% | 123.80% |
| Normalized Basic EPS | -0.39% | 64.68% | 48.48% | 108.78% | 59.75% |
| EPS Diluted | 11.40% | 265.22% | 125.00% | 392.81% | 123.80% |
| Normalized Diluted EPS | -0.39% | 63.95% | 47.21% | 107.35% | 59.75% |
| Average Basic Shares Outstanding | -0.87% | 0.86% | 1.76% | 1.90% | 3.02% |
| Average Diluted Shares Outstanding | -0.87% | 1.29% | 2.64% | 2.59% | 3.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |